secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bone Biologics Corp (BBLG)
CIK:        0001419554
Form:       8-K
Filed at:   2023-06-06T23:59:59+00:00
Accession:  0001493152-23-020241
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bone Biologics effects 1-for-30 reverse stock split effective June 5, 2023
--------------------------------------------------------------------------

- 1-for-30 reverse split of common stock and warrants effective June 5, 2023; par value unchanged.
- Stockholder approval via written consent on May 1, 2023; no fractional shares, rounding up.
- Trading on Nasdaq on split-adjusted basis from June 7, 2023; new CUSIP 098070402 (common) and 098070154 (warrants).
- Proportionate adjustments to exercise prices and shares reserved under equity plans and outstanding options/warrants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1419554/000149315223020241/0001493152-23-020241-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1419554/000149315223020241/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-020241

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer